Year To Quarter End Consolidated Statement Of Comprehensive Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7300559

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,825,000,000 JPY
2,838,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-229,000,000 JPY
2,105,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-36,000,000 JPY
-22,000,000 JPY
Other comprehensive income
-266,000,000 JPY
2,082,000,000 JPY
Comprehensive income
2,558,000,000 JPY
4,921,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,558,000,000 JPY
4,921,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.